Feb 1, 2023USH2AUSHER SYNDROME COALITIONUsher Syndrome Coalition |usher-syndrome.org | Westford, MA | 800.946.9203 Mission The Usher Syndrome Coalition’s mission is to raise...
Jan 31, 2022USH2AProQR seeking Clinical Trial Participants Usher Syndrome Coalition announces partnership with ProQR to support clinical trial enrollment for a potential therapy for USH2A.
Dec 21, 2021Clinical TrialFirst patients dosed in phase 2/3 gene therapy trial for retinitis pigmentosaThe first patients have been dosed in the phase 2/3 Sirius and Celeste clinical trials investigating QR-421a in patients with USH2A.
May 24, 2021USH2AClinical Trial News: Positive results in Usher syndrome and RP clinical studyProQR news – Positive results achieved in our ongoing Usher syndrome and retinitis pigmentosa research.
Jul 9, 2020USH2AA Review of Gene, Drug and Cell-Based Therapies for Usher SyndromeLucy S. French, Carla B. Mellough, Fred K. Chen, and Livia S. Carvalho | Frontiers Cell. Neuroscience | 09 July 2020 | Sec. Cellular...
Dec 31, 2019USH2AUSH2A Gene in Retinitis Pigmentosa: A Tale of Three PatientsBy Patricia C Sanchez Diaz, DVM, PhD, FAAO Purpose This report aims to illustrate the impact of genetic testing in the diagnosis and...
Dec 15, 2018USH2ARetinitis Pigmentosa and Allied DisordersFrom such work, a “multiprotein scaffold complex” model has been proposed for harmonin, whirlin, and sans.
Apr 22, 2016USH2APanel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis PigmentosaTargeted next-generation sequencing (NGS) has been demonstrated to be an effective strategy for the detection of mutations in RP.